Erik Harris, EVP & Chief Commercial Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 700 shares at $113.68 ($80K) on 2021-05-06, disclosed to the SEC on 2021-05-10.
Scheduled sale ($80k) by EVP & Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $113.68 | 307 | $35K | 43.9% |
| 2 | $113.67 | 393 | $45K | 56.1% |
| Total | $113.67 avg | 700 | $80K | 100% |
| Filing → |
| RARE | SELL | 2024-03-05 | $513K | — | Filing → |
| RARE | SELL | 2023-09-06 | $228K | — | Filing → |
| RARE | SELL | 2023-06-21 | $15K | — | Filing → |